MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijmyco.2015.10.001

Медицинская библиотека · International journal of mycobacteriology · 2015

Antituberculosis drugs and hepatotoxicity among hospitalized patients in Jos, Nigeria.

Isa Samson E, Ebonyi Augustine O, Shehu Nathan Y, Idoko Patrick, Anejo-Okopi Joseph A, Simji Gomerep, Odesanya Rachael U, Abah Isaac O, Jimoh Hafsat O

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Tuberculosis (TB) could be fatal if left untreated, however, adverse effects of anti-TB medications (anti-TBs) themselves may limit treatment. We determined the incidence and clinical characteristics of hepatotoxicity in hospitalized patients receiving first-line anti-TB treatment.

METHODS

A retrospective cohort study of patients aged ⩾18years seen at the medical wards of the Jos University Teaching Hospital from January 2013 to June 2013 was carried out. Data were retrieved for 110 patients who were prescribed anti-TBs. Their demographic and clinical characteristics were described, and the incidence of symptomatic hepatotoxicity determined. The incidence of hepatotoxicity by strict American Thoracic Society criteria (symptomatic hepatotoxicity plus alanine transaminase in IU/L levels >3×upper limit of normal) was also determined.

RESULTS

Twenty patients developed symptomatic hepatotoxicity, giving an incidence of 18.2%. Furthermore, 18 (16.4%) patients had hepatotoxicity according to the American Thoracic Society criteria. Those with symptomatic hepatotoxicity unexpectedly had lower baseline alanine transaminase interquartile range (IQR) (35 [16-63] vs. 67 [4-226]; p=.04) and bilirubin (μmol/L): total IQR (15.3 [10.2-74.8] vs. 20.4 [20.4-20.4]; p=.01) and conjugated IQR (7.6 [5.1-34.8] vs. 10.2 [10.2-10.2]; p=.004). However, there were no significant differences in age, sex, body mass index, and duration of anti-TB treatment, human immunodeficiency virus infection status, antiretroviral therapy status, alcohol consumption, and the presence of hepatitis B surface antigen or hepatitis C virus antibody.

CONCLUSION

Hepatotoxicity due to first-line anti-TBs, whether based on clinical features alone or backed by liver chemistry, is common among hospitalized patients in our environment. Studies to determine the predictors of hepatotoxicity to guide clinical interventions aimed at the prevention or timely identification of cases are needed.

Для цитирования: Isa Samson E, Ebonyi Augustine O, Shehu Nathan Y, Idoko Patrick, Anejo-Okopi Joseph A, Simji Gomerep, Odesanya Rachael U, Abah Isaac O, Jimoh Hafsat O. Antituberculosis drugs and hepatotoxicity among hospitalized patients in Jos, Nigeria.. International journal of mycobacteriology. 2015. DOI: 10.1016/j.ijmyco.2015.10.001.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.